Back to Resource Hub Article

The Case for Integrating Study Supply and Clinical Supply Chain Systems

Managing clinical trial supplies is a delicate balancing act. Too little product means delays and disruptions, while too much leads to costly waste.

In oncology trials, where investigational drugs and comparators are especially expensive, the stakes are high. But there is a way to cut costs while maintaining efficiency.

In this article, discover how an integrated Free Picking (Just-in-Time) IRT/RTSM system can help sponsors optimize their supply chain.

Learn how it reduces the risk of overproduction and minimizes unnecessary waste.

From navigating the dilemma of buffer sizing to exploring drug pooling strategies, this solution offers a smarter, more cost-effective way to manage clinical trial supplies.

Similar posts

Looking for more insights? Explore related resources.

BLOG POST

Revolutionizing Clinical Trial Supply Management with Signant SmartSignals® RTSM: Unveiling the Power of Free Picking

VISIT THE BLOG
ARTICLE

Strategies for Continued IRT Success During COVID-19

READ THE ARTICLE
BROCHURE

Signant Health Corporate Overview

SEE THE BROCHURE

Get notified on new marketing insights

Here mention the benefits of subscribing